August 04, 2025 08:05 ET | Source: MaxCyte, Inc MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support development of…
License agreement supports Madrigal’s pipeline strategy to develop innovative combination treatments for MASH, anchored by its foundational therapy Rezdiffra™ (resmetirom)…
Urges Government to Uphold Competitive Balance and Spectrum Equity in Broadcasting Sector NEW DELHI, July 19, 2025 /PRNewswire/ -- The All…
New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) -- Ripple (XRP) is gradually getting rid of the regulatory shadow…
Exclusive agreement includes over $70 million in upfront and milestone payments to LENZ in addition to double-digit royalties on net…